Intrapleural Saline for Pleural Empyema
(FLO Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial investigates whether saline solution can help treat pleural empyema, a condition where pus collects around the lungs. Researchers aim to determine if saline can aid recovery without more intense treatments, such as clot-dissolving medications or surgery. Participants will receive saline through their chest tube, and if it proves ineffective, additional treatments may be necessary. Eligible participants have complicated chest infections requiring fluid drainage and can provide consent. As a Phase 4 trial, this research involves an FDA-approved treatment and seeks to understand how it can benefit more patients.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you are on anticoagulation (blood thinners) or have active bleeding, you may not be eligible to participate.
What is the safety track record for intrapleural saline?
Research has shown that using saline in the pleural space (the area between the lungs and chest wall) is generally safe. Although specific data on saline alone is limited, the trial's advanced stage suggests it is safe enough to test for effectiveness in this setting.
If the saline treatment proves ineffective, the trial includes a backup plan to use medications like alteplase and dornase alfa, which help dissolve blood clots. These medications have undergone more extensive study and show promising results. For instance, only about 1.8% of patients experienced significant bleeding, primarily those with existing bleeding risks. Overall, these treatments are considered a safe alternative to surgery for pleural infections.
In summary, the trial supports the use of saline due to its safety in advanced trials, and the potential follow-up treatments have demonstrated safety in other studies.12345Why are researchers enthusiastic about this study treatment?
Unlike the standard treatment for pleural empyema, which often involves antibiotics and invasive procedures like surgery or chest tube drainage, the use of intrapleural saline is unique because it offers a simpler, less invasive approach. Researchers are excited about this treatment because it uses saline to potentially loosen and clear the infection without immediate reliance on more aggressive interventions. This approach might reduce recovery time and hospitalization, providing a more comfortable and efficient option for patients.
What evidence suggests that intrapleural saline might be an effective treatment for pleural empyema?
Studies have shown that using saline (a saltwater solution) in the chest can help treat pleural empyema, an infection in the chest cavity. Research suggests that saline may thin and wash away the infection, potentially speeding up chest tube removal and reducing the need for surgery. Although few studies focus on using saline alone for this condition, it is considered safe and is being explored as a simpler, less invasive treatment. In this trial, all patients will initially receive intrapleural saline as part of a step-by-step treatment plan, with additional treatments like medications that dissolve blood clots available if necessary.23678
Are You a Good Fit for This Trial?
This trial is for people with infections or cancer affecting the space around their lungs (pleural space), such as pleural empyema, parapneumonic effusion, or malignant pleural mesothelioma. Participants must already have a chest tube in place.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment - Intrapleural Saline
Participants receive intrapleural saline every 8 hours for 3 days through an existing chest tube
Treatment - Intrapleural Fibrinolytics
If no improvement, participants receive intrapleural tPA/DNase every 12 hours for 3 days
Surgery Consultation
If significant fluid remains, participants are referred for thoracic surgery consultation
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Intrapleural Alteplase
- Intrapleural Dornase Alfa
- Intrapleural Saline
Trial Overview
The study tests if flushing the pleural space with saline through a chest tube helps clear infection. If this doesn't work, patients may get medications (alteplase and dornase) to break up fluid, and surgery if needed. The main focus is on how quickly the chest tube can be removed.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
All patients will be in a single arm and escalated from intraplerual saline to tPA/DNAse followed by surgery as warranted based on protocol criteria.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dartmouth-Hitchcock Medical Center
Lead Sponsor
Citations
Can intrapleural alteplase treatment be an alternative ... - PMC
However, as seen in our study, intrapleural alteplase application is at least as effective as VATS-D in terms of treatment success. Keywords: pleural empyema, ...
A retrospective review of concurrent versus sequential ...
The primary objective of this study was to assess the safety and effectiveness of concurrent versus sequential intrapleural tPA and DNase in pleural infections.
Intrapleural Tissue Plasminogen Activator and Dornase ...
A factorial randomized clinical trial of 210 adults with pleural empyema reported improved outcomes with the use of DNase and tPA compared ...
Intrapleural Use of Tissue Plasminogen Activator and ...
Intrapleural t-PA–DNase therapy improved fluid drainage in patients with pleural infection and reduced the frequency of surgical referral and the duration of ...
Understanding the systemic effects of intrapleural tPA and ...
Intrapleural tPA and DNase are effective treatments for complicated pleural effusions but the therapy comes with some increased risk of intrapleural bleeding.
Intrapleural tissue plasminogen activator and ... - PMC
In our series significant pleural bleeding occurred in only 2 of 107 (1.8%) patients given tPA/DNase; both had underlying bleeding risks. There were no episodes ...
Safety and efficacy of reduced dose intrapleural alteplase and ...
Our data suggest that 2.5mg alteplase and 5mg DNase is safe and effective even in high risk patients. A larger prospective study will be needed to confirm this.
Intrapleural DNase and Tissue Plasminogen Activator in ...
This is a multi-centre randomized controlled trial comparing the time to discharge from hospital after chest drain insertion in previously well children who ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.